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Medullary Thyroid Carcinoma: Australian Experience with 
Genetic Testing 
Janet L. Ward,* Valentine J. Hyland,* David S. Andrew,* Debbie J . Marsh,' 
and Bruce G. Robinson* 
Linkage analysis has been performed in four pedigrees with multiple endocrine neoplasia type 2A 
(MEN 2A) or familial medullary thyroid carcinoma (MTC) using pericentromeric chromosome 10 
probes. Important information regarding carrier status has been provided in 10 individuals, many of 
whom would not have heen identified by pentagastrin stimulation testing. We have also used pulsed 
field gel electrophoresis (PFGE) to link the probes H4JRBP and pMCK2 to a 150 kb fragment. Using 
PFGE, no evidence was found in DNA from lymphocytes of a major DNA rearrangement in two 
individuals affected with MEN 2A and an individual with MEN2B compared with normals. Metastatic 
MTC from one patient has been used to generate a cDNA library which will be used to screen for 
candidate MEN 2A and MEN 2B gene(s). (Henry Ford Hosp MedJ 1992;40:220-3) 
The identification of carriers of the gene(s) responsible for the development of the multiple endocrine neoplasia type 
2A (MEN 2A) syndrome has traditionally relied on provocative 
pentagastrin-stimulated calcitonin testing. Difficulties are fre-
quendy encountered in the interpretation of this test. These in-
clude dependence upon age at time of test performance and non-
parallelism of diluted samples to the assay standard curve. In "at 
risk" individuals the test should ideally be repeated annually in 
an attempt to identify the prematignant stage of C-cell hyperpla-
sia. 
The availability of closely hnked fianking markers for the 
MEN 2A (1,2) locus has made it possible to accurately predict 
gene carrier status on a single blood sample when linkage has 
been established in the family. 
We have performed linkage analysis in four of six Australian 
families with either MEN 2A or familial medullary thyroid car-
cinoma (MTC) and have been able to provide important carrier 
status information to 10 individuals. 
In addition, we have performed pulsed field gel electro-
phoresis (PFGE) to improve the genetic map in the lOql 1.2 re-
gion and have generated a cDNA library from MTC which will 
be helpful in the isolation of candidate MEN 2A gene(s). 
Materials and Methods 
Linkage analysis 
Genomic DNA used for linkage analysis was extracted from 
peripheral blood leukocytes by a method described previously 
(3). Restriction enzyme digested DNA was electrophoresed in 
0.8% agarose gels and transferred to nylon filters (Genescreen 
Plus) by Southem blotting (4). 
Probes 
Eight probes (H4.IRBP [RBP3], pMCK2 [D10S15], TB10.163 
[D10S22J, and pGEM-32 [FNRB]) were used to study linkage 
relationships in four fainilies. Gel isolated fragrnents of the cos-
mid probes MEN203 and cIRBP.9 (RBP3) were also used in 
linkage analysis. A 9 kb DNA fragment isolated by a Noti, 
Bglll double digestion of the cosmid MEN203 detected the 
Bglll polymorphism but stdl contained some repetitive se-
quences. A subsequent Mspl digestion of the above fragment 
isolated a unique 2.2 kb subfragment which also detected the 
Bgll l polymorphism. A unique 3 kb fragment isolated by a 
Noti, TaqI double digestion of the cosmid probe cIRBP.9 de-
tected the TaqI polymorphism. The probes H4.IRBP and 
pMCK2 were also used in pulsed field gel analysis. 
Insert DNA was isolated from the probes and labeled with 
random primers to a specific activity of 1 x 10^  cpm/|ag. Filters 
were hybridized ovemight. Final washes were in 2 x SSC, 1% 
SDS at 42 °C, or 0.1 x SSPE, 0.1% SDS at 65 °C. Filters were 
stripped in 0.2N NaOH and checked for removal of probe prior 
to reuse. 
Pulse field gel electrophoresis 
PFGE was perfoimed on DNA from our control individuals. 
In two controls, DNA was obtained from independent lympho-
blastoid cell lines and in the other two controls DNA was ob-
tained from lymphocytes isolated from fresh blood. The DNA 
from two independent MEN 2A individuals and the MEN 2B in-
dividual was isolated from lymphocytes of fresh blood. DNA 
was isolated from the lymphoblastoid cell line CY6. This cell 
line contains a single 10:16 translocation in a mouse, A9 back-
ground. The chromosome 10 content was 10pter-10q26 (this 
cell line was provided by D. F. Callen). 
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Fig I—DNA typing of family I with closely linked markers. 
Solid circlelsolid square = individuals with proven MEN 2A. 
Numbers in symbols indicate age in years at last pentagastrin 
stimulation test. -¥ or - = positive or negative test result. 
A Pharmacia PFGE apparatus with a hexagonal electrode was 
used. The buffer was 0.5 x TBE and the gel was 1 % agarose (Be-
thesda Research Laboratories). DNA in 0.7% low melting point 
agarose (Pharmacia) was digested with restriction endonu-
cleases Not 1, Nru 1, and Mlu 1 (New England Biolabs). Samples 
were electrophoresed at 150 mA constant current, 5 °C, with a 
switching of 70s for 30 hours. To resolve the 1,600 kb Mlul 
fragment, the buffer was reduced to 0.25 x TBE and the samples 
electrophoresed at 80 mA constant current, 5 °C, with a switch-
ing of 1,200s for five days, and then with a switching of 70s for 
20 hours. 
cDNA library 
Total RNA was prepared from metastatic MTC in a cervical 
lymph node by standard GTC/CsCl procedures (5). From 70 [ig 
total RNA, 5.92 ng poly A+ RNA was collected by column chro-
matography using oligo dT cellulose columns (Pharmacia). 
The cDNA library was constructed using the lambda ZAP-
cDNA synthesis kit (Stratagene). 
Results 
Linkage analysis 
We have collected data on six families with either MEN 2A or 
familial MTC and have performed linkage analysis in four of 
these families. The results of linkage analysis are shown in Figs 
1 and 2. 
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Fig 2—DNA typing of family 3 with closely linked markers. 
Solid circlelsolid square = individuals with proven MEN 2A. 
Half-filled circles/half-filled squares = individuals with famil-
ial MTC. Half-shaded circles/half-shaded .squares = individu-
als with Hirchsprung's disease. Numbers in symbols indicate 
age in years at last pentagastrin stimulation test, -t- or - = posi-
tive or negative test result. 
Several ob.servations can be rnade from our famities. Individ-
ual III-2 in pedigree 1 (Fig 1) has a high probability of being a 
gene carrier. In pedigree 2 a recombination event has been iden-
tified in one individual between the RBP3 and D10S22 
(TBI0.163) loci. In pedigree 3 (Fig 2) the index case II-3 has 
both Hirschprung's disease and MTC. Several of this individ-
ual's siblings died in infancy or childhood with complications 
of Hirschpmng's disease. Hirschprung's disease and MTC do 
not appear to be linked in this family as individual III-2 has 
MTC but normal bowel function. Southern analysis of DNA ex-
tracted from stored paraffin blocks of tissue from individual II-1 
in pedigree 3 was not possible as the DNA was degraded. Link-
age analysis has been particularly helpful in individual III-l in 
this pedigree as the result of an initial pentagastrin stimulation 
test revealed nonparallelism of diluted samples to the assay 
standard curve. Pedigree 4 has been uninformative when ana-
lyzed with six different linked probes. Blood samples are cur-
rently being collected from individuals in pedigree 5, which is 
also of interest in that two individuals have recently developed 
positive pentagastrin stimulation tests. DNA samples from ped-
igree 6 are being obtained. 
Linkage analysis in our families has been particularly helpful 
in establishing that one individual, aged 8 years, is a gene carrier 
and that nine individuals between the ages of 8 and 35 years 
have been reasonably excluded as gene carriers. Flanking mark-
ers have been informative only in pedigree 3. 
Pulsed field gel mapping 
Results are shown in Tables 1 and 2 and Fig 3 (A and B). 
H4.1RBP and pMCK2 hybridize to Noti restriction fragments 
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Table 1 
Hybridization with H.4IRBP 
Table 2 
Hybridization with pMCK2 
Cell Restriction Endonuclease Cell Restriction Endonuclease 
Line Noti Nrul Mlul Line Noti Nrul Mlul 
Controls 1 and 2 100 kb 800 kb 150, 250, 600, 750, Controls 1 and 2 400 kb 800 kb 150, 2.50, 600, 750, 
and 1,600 kb and 1,600 kb 
Controls 3 and 4* 100 kb 800, 150,250,600,750, Controls 3 and 4* 400 kb 800, 150,250,600,750, 
900 kb and 1,600 kb 900 kb and 1,600 kb 
CY6 ND 800 kb 250 and 1,600 kb CY6 ND 800 kb 250 kb 
MEN2A 1 and 2/ Nl) 800 kb 150, 250, 600, MEN2A I and 2/ ND 800 kb 1.50, 2.50, 600, 
MEN2B1 750, and 1,600 kb MEN2B1 750, and 1,600 kb 
*No Mlul hybridization fragments were detected. 
ND - not determined. 
*No Mlul hybridization fragments were detected. 
ND = not determined. 
of 100 kb and 400 kb, respectively. Both probes hybridized to an 
800 kb Nrul restriction fragment for controls 1 and 2, and to 800 
and 900 kb Nml restriction fragments for controls 3 and 4. In 
addition, both probes hybridized to Mlu 1 restriction fragments 
of 150,250,600,750, and 1,600 kb for three of the four controls. 
DNA from control 4 that hybridized to the two probes was unre-
solved on the gels. The pattem of hybridization to the Mlul re-
striction fragments indicates partial restriction of DNA at the 
Mlul restriction sites adjacent to or in the RBP3 and DIGS 15 
loci. For CY6, H4.IRBP hybridized to Mlul fragments of 250 
and 1,600 kb and pMCK2 hybridized to only a 250 kb Mlu 1 re-
striction fragment. This indicates that the genomic sequence for 
1 2 3 4 5 6 7 8 910 11 1? 
/ 
C IIA IIA i l B C r H 
RBP3, on the 10:16 translocation, contains an Mlul restriction 
site and the 250 and 1,600 kb restriction fragments are adjacent 
on the chromosome. 
No change in the pattem of hybridization was observed for 
the two MEN 2A or MEN 2B individuals. No detectable rear-
rangement of the RBP3 or DlOSl5 loci was observed in these 
individuals in DNA from lymphocytes. 
cDNA Library 
The cDNA library which was generated from metastatic 
MTC is currently being screened for candidate genes. 10^  clones 
are being screened initially using a fiow-sorted human chromo-
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Fig 3—A) autoradio graph (left) of filter hybridized with H4.IRBP, and B) autoradiograph (right) ofthe same filter hybridized with 
pMCK2. Lane 1, control I MM; lane 2, control I Nrul; lane 3, MEN2A-1 Mlul; lane 4, MEN2A-1 Nrul; lane 5, MEN2A-2 Mlul; lane 
6, MEN2A-2 Nrul; lane 7, MEN2B-1 Mlul; lane 8, MEN2B-2 Nrul; lane 9. control 3 Mlul; lane 10, control 3 Nrul; lane 11, CY6 
Mlul; lane 12. CY6 Nrul. DNA standards are shown to the left of lane I in photograph B; the L DNA standards are concatamers of 
Lambda cI857 (New England Biolabs); and the Y DNA standards are yeast chromosome markers of Saccharomyces cerevisae strain 
YPH80 (New England Biolabs). Faint signals are highlighted with a solid square. 
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some 10 library (ATCC 57736). The insert sizes of six random 
recombinant clones ranged from 0.5 to 2 kb. 
A panel of hybrid cell lines will then be used to identify those 
clones which localize to the centromeric region of chromosome 
10. 
Discussion 
Accurate identification of MEN 2A gene carriers is now pos-
sible using probes closely linked to the gene for MEN 2A 
(MEN2A). This enables intensive follow-up of identified carri-
ers with annual pentagastrin stimulation testing and enables 
early identification of premalignant C-cell hyperplasia. Thy-
roidectomy in patients with only C-cell hyperplasia has been 
shown (6) to significantly reduce morbidity and mortality due to 
MTC. In contrast, tho.se individuals in whom the gene(s) is not 
present do not require regular pentagastrin testing. It is unlikely 
that the gene carrier we have identified would have been identi-
fied by pentagastrin testing because of the low sensitivity of this 
test at ages less than 12 years (7). 
MEN2A has been linked to the lOql 1.2 region (8), and since 
recombination fractions in the pericentromeric regions of chro-
mosomes may underestimate the physical distance between the 
locus and linked markers, we have begun constructing a physi-
cal map ofthe lOql 1.2 region. Our data show that two markers, 
pMCK2 and H4.IRBP, are linked by a 150 kb Mlul fragment. 
Orientation ofother markers and the use of hybrid cell lines in 
PFGE wdl enable further expansion of this map. 
Since our PFGE data do not indicate major DNA rearrange-
ment in DNA of lymphocytes from patients with MEN 2A, we 
have commenced screening of an MTC cDNA library based on 
the hypothesis that pathogenic mRNA molecules should be ex-
pressed in MTC. Those cDNAs which are mapped to lOql 1.2 
will be examined closely as potential MEN2A candidate genes. 
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